← Product Code [HRS](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HRS) · K122308 # AXSOS DISTAL LATERAL FEMUR TS LONG PLATES (K122308) _Howmedica Osteonics Corp., Dba Stryker Orthopaedics · HRS · Oct 1, 2012 · Orthopedic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HRS/K122308 ## Device Facts - **Applicant:** Howmedica Osteonics Corp., Dba Stryker Orthopaedics - **Product Code:** [HRS](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HRS.md) - **Decision Date:** Oct 1, 2012 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 888.3030 - **Device Class:** Class 2 - **Review Panel:** Orthopedic - **Attributes:** Therapeutic ## Indications for Use The AxSOS™ Locking Plate System is intended for use in long bone fracture fixation. The system is indicated for fixation of long bone fractures including but not limited to fractures of the humerus, tibia and femur. ## Device Story AxSOS™ Distal Lateral Femur TS Long Plates are metallic bone fixation implants; line extension of existing AxSOS™ Locking Plate System. Device consists of monoaxial plates used for internal fixation of long bone fractures. Plates are surgically implanted by orthopedic surgeons to stabilize fractures; provide mechanical support during bone healing. Device is a passive implant; no electronic or software components. Substantial equivalence established via comparison to predicate; non-clinical testing included static and fatigue strength evaluation per ISO 14971 risk management standards. ## Clinical Evidence Bench testing only. Static and fatigue strength testing performed to demonstrate mechanical equivalence to predicate devices. Risk analysis conducted per ISO 14971:2007. ## Technological Characteristics Metallic bone fixation plate; stainless steel construction; monoaxial design; available in two lengths (18-20 hole configurations); intended for internal surgical fixation; passive implant; no energy source or software. ## Regulatory Identification Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system. ## Predicate Devices - AxSOS™ Locking Plate System ([K061012](/device/K061012.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ OCT 1 2012 # 510(k) Summary of Safety and Effectiveness AxSOS™ Locking Plate System Proprietary Name: ### AxSOS™ Locking Plate System Common Name: Bone plates Classification Name and Reference: Single/multiple component metallic bone fixation appliances and accessories, 21 CFR \$888.3030 Regulatory Class: Product Codes: Predicate Devices: For Information contact: Class II 87 HRS: Plate, Fixation, Bone AxSOS™ Locking Plate System Estela Celi Howmedica Osteonics Corp. 325 Corporate Drive Mahwah. NJ 07430 Phone: (201) 831-6461 Fax: (201) 831-6038 Estela.Celi(@stryker.com Date Prepared: September 27, 2012 #### Description This Special 510(k) submission is a line extension to address modifications made to the AxSOS™ Locking Plate System which was cleared in K061012. This line extension is to add four femoral long plates to the existing size range of the AxSOS™ Locking Plate System. These monoaxial long plates will be known as AxSOS™ Distal Lateral Femur TS (Threaded Shaft) Long Plates and will be available in two lengths in left and right configurations. ### Intended Use The AxSOS™ Distal Lateral Femur TS Long Plates line extension does not alter the intended use of the predicate AxSOS™ Locking Plate System as cleared in K061012. The indications for use for the subject plates are provided below. #### Indications The AxSOS™ Locking Plate System is intended for use in long bone fracture fixation. The system is indicated for fixation of long bone fractures including but not limited to fractures of the humerus, tibia and femur. {1}------------------------------------------------ # Substantial Equivalence: The AxSOS™ Distal Lateral Femur TS Long Plates are substantially equivalent to the AxSOS™ · Distal Lateral Femur TS Plates of the AxSOS™ Locking Plate System cleared under K061012 in regards to intended use, design, materials, and operational principles as a bone fixation device. | AxSOSTM Locked Plating Comparison of Subject to Predicate | | | |-----------------------------------------------------------|------------------------------------------------------------------|---------------------------------------------------------------| | | Subject Device
AxSOSTM Distal Lateral Femur
TS Long Plates | Predicate Device
AxSOSTM Distal Lateral
Femur TS Plates | | 510(k) | Pending | K061012 | | Intended Use | Fractures of the Distal Femur | Fractures of the Distal Femur | | Design | Monoaxial Plates | Monoaxial Plates | | Material | Stainless Steel | Stainless Steel | | Plate Sizes | 2 lengths/18-20 hole plates | 7 lengths/4-16 hole plates | # Summary of Non-Clinical Testing and Evaluation - Risk analysis was performed according to the requirements of ISO 14971:2007 "Medical Devices-Application of risk management to medical devices." Records of the risk analysis process are retained in the design history file. Static strength as well as fatigue strength testing has demonstrated the subject plates are substantially equivalent to the predicate devices. {2}------------------------------------------------ # DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 OCT 1 2012 Howmedica Osteonics Corporation % Ms. Estella Celi Regulatory Affairs 325 Corporate Drive Mahwah. New Jersey 07430 Re: K122308 Trade/Device Name: AxSOS™ Distal Lateral Femur TS Long Plates Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and acccesories Regulatory Class: II Product Code: HRS Dated: September 11, 2012 Received: September 12, 2012 Dear Ms. Celi: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act {3}------------------------------------------------ ### Page 2 - Ms. Estella Celi or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, sincerely yours, Kuma Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ### APPENDIX E-1 #### Indication for Use Statement Indications for Use 510(k) Number (if known): Device Name: AxSOSTM Distal Lateral Femur TS Long Plates Indications for Use: The AxSOS™ Locking Plate System is intended for use in long bone fracture fixation. The system is indicated for fixation of long bone fractures including but not limited to fractures of the humerus, tibia and femur. Asit (Division Sign-Oft) Division of Surgical, Orthopedic, and Restorative Devices 510(k) Number k122308 Over-The-Counter Use Prescription Use X AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) --- **Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HRS/K122308](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HRS/K122308) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com